United States · FDA National Drug Code directory

PIOGLITAZONE HYDROCHLORIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62135-804_42c9ddc6-1aae-a645-e063-6294a90a8b1a
Product NDC: 62135-804
Form: TABLET
Composition / generic term: PIOGLITAZONE HYDROCHLORIDE
Labeler: Chartwell RX, LLC
Marketing category: ANDA
Marketing start / end (source format): 20201028
Source listing expiry: 20261231

Source-listed ingredients

PIOGLITAZONE HYDROCHLORIDE — 15 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET in 1 BOTTLE (62135-804-30) · 62135-804-30
90 TABLET in 1 BOTTLE (62135-804-90) · 62135-804-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →